{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:52:26Z","timestamp":1778565146433,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejphar.2022.175209","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T14:34:07Z","timestamp":1660746847000},"page":"175209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Serum cholesterol increase in statin users associated with antibiotic use: Case-crossover study"],"prefix":"10.1016","volume":"932","author":[{"given":"Idit","family":"Lavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4369-6813","authenticated-orcid":false,"given":"Naomi","family":"Gronich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejphar.2022.175209_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","article-title":"Safety and efficacy of statin therapy","volume":"15","author":"Adhyaru","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2022.175209_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2022.175209_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/00365549109105189","article-title":"Comparative effects of clarithromycin and erythromycin on the normal intestinal microflora","volume":"23","author":"Brismar","year":"1991","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2022.175209_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/BF02009388","article-title":"Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora","volume":"12","author":"Brismar","year":"1993","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175209_bib5","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/CMR.00086-12","article-title":"Antianaerobic antimicrobials: spectrum and susceptibility testing","volume":"26","author":"Brook","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175209_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chron. Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175209_bib7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"issue":"7410","key":"10.1016\/j.ejphar.2022.175209_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nature11319","article-title":"Gut microbiota composition correlates with diet and health in the elderly","volume":"488","author":"Claesson","year":"2012","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.ejphar.2022.175209_bib9","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175209_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/infdis\/jix604","article-title":"Protection of the human gut microbiome from antibiotics","volume":"217","author":"de Gunzburg","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175209_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060280","article-title":"The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing","volume":"6","author":"Dethlefsen","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2022.175209_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nchembio.1864","article-title":"A biosynthetic pathway for a prominent class of microbiota-derived bile acids","volume":"11","author":"Devlin","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175209_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.601","article-title":"Gut bacterial microbiome composition and statin intake-A systematic review","volume":"8","author":"Dias","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.ejphar.2022.175209_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature13178","article-title":"Dynamics and associations of microbial community types across the human body","volume":"509","author":"Ding","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejphar.2022.175209_bib15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41591-019-0533-0","article-title":"Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution","volume":"25","author":"Doan","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2022.175209_bib16","first-page":"185","article-title":"Impact of cefuroxime-axetil on the normal intestinal microflora","volume":"6","author":"Edlund","year":"1993","journal-title":"Microb. Ecol. Health Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175209_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/34.1.127","article-title":"The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances","volume":"34","author":"Edlund","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejphar.2022.175209_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/00365540050164272","article-title":"Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora","volume":"32","author":"Edlund","year":"2000","journal-title":"Scand. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175209_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1574-6941.2006.00112.x","article-title":"Analysis of treatment effects on the microbial ecology of the human intestine","volume":"57","author":"Engelbrektson","year":"2006","journal-title":"FEMS Microbiol Ecol"},{"key":"10.1016\/j.ejphar.2022.175209_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bcp.2016.09.007","article-title":"Antibiotic use and microbiome function","volume":"134","author":"Ferrer","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175209_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/00365549409011783","article-title":"Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis","volume":"26","author":"Floor","year":"1994","journal-title":"Scand. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175209_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/joim.12186","article-title":"Use of self-controlled designs in pharmacoepidemiology","volume":"275","author":"Hallas","year":"2014","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175209_bib23","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1021\/acs.jproteome.6b00984","article-title":"Gut microbiota modulation attenuated the hypolipidemic effect of simvastatin in high-fat\/cholesterol-diet fed mice","volume":"16","author":"He","year":"2017","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175209_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/antibiotics9040191","article-title":"Frimodt-m\u00f8ller N effects of antibiotics on the intestinal microbiota of mice","volume":"9","author":"Hertz","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejphar.2022.175209_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/00365528609003109","article-title":"Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects","volume":"21","author":"H\u00f8verstad","year":"1986","journal-title":"Scand. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175209_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009836","article-title":"Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome","volume":"5","author":"Jakobsson","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175209_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.metabol.2004.07.019","article-title":"Effect of antibiotics as cholesterol-lowering agents","volume":"54","author":"Jenkins","year":"2005","journal-title":"Metabolism"},{"issue":"Pt 11","key":"10.1016\/j.ejphar.2022.175209_bib28","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1099\/mic.0.040618-0","article-title":"Long-term impacts of antibiotic exposure on the human intestinal microbiota","volume":"156","author":"Jernberg","year":"2010","journal-title":"Microbiology"},{"issue":"5","key":"10.1016\/j.ejphar.2022.175209_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14712598.2013.758706","article-title":"Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications","volume":"13","author":"Jones","year":"2013","journal-title":"Expet Opin. Biol. Ther."},{"issue":"10","key":"10.1016\/j.ejphar.2022.175209_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025482","article-title":"Enteric microbiome metabolites correlate with response to simvastatin treatment","volume":"6","author":"Kaddurah-Daouk","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.175209_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-9236(98)90151-5","article-title":"Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations","volume":"64","author":"Kantola","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6285","key":"10.1016\/j.ejphar.2022.175209_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ejphar.2022.175209_bib33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1473-3099(19)30272-5","article-title":"Taiwan gastrointestinal disease and Helicobacter consortium. Long-Term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial","volume":"19","author":"Liou","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejphar.2022.175209_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fmicb.2018.00530","article-title":"Gut microbiome associates with lipid-lowering effect of rosuvastatin in vivo","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175209_bib35","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/jac\/dkl420","article-title":"Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp","volume":"58","author":"L\u00f6fmark","year":"2006","journal-title":"Resistance Genes Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175209_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1473-3099(18)30676-5","article-title":"Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study","volume":"19","author":"Low","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"24","key":"10.1016\/j.ejphar.2022.175209_bib37","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175209_bib38","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/pds.1438","article-title":"'Why me?' versus 'why now?'--differences between operational hypotheses in case-control versus case-crossover studies","volume":"16","author":"Maclure","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2022.175209_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2012.10.052","article-title":"Xenobiotics shape the physiology and gene expression of the active human gut microbiome","volume":"152","author":"Maurice","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2022.175209_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/joc.1997.9.3.203","article-title":"Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections","volume":"9","author":"Mavromanolakis","year":"1997","journal-title":"J. Chemother."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175209_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy289","article-title":"Effect of commonly used pediatric antibiotics on gut microbial diversity in preschool children in Burkina Faso: a randomized clinical trial","volume":"5","author":"Oldenburg","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.ejphar.2022.175209_bib42","first-page":"17","article-title":"Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin","volume":"7","author":"Orrhage","year":"1994","journal-title":"Microb. Ecol. Health Dis."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175209_bib43","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/gutjnl-2012-303184","article-title":"Gut microbiota disturbance during antibiotic therapy: a multi-omic approach","volume":"62","author":"Perez-Cobas","year":"2013","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175209_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microb."},{"key":"10.1016\/j.ejphar.2022.175209_bib45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.RES.33.4.393","article-title":"Effect of neomycin and other antibiotics on serum cholesterol levels and on 7alpha-dehydroxylation of bile acids by the fecal bacterial flora in man","volume":"33","author":"Samuel","year":"1973","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2022.175209_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2022.175209_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12014-019-9252-2","article-title":"Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis","volume":"16","author":"Sharma","year":"2019","journal-title":"Clin. Proteonomics"},{"issue":"7610","key":"10.1016\/j.ejphar.2022.175209_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature18846","article-title":"Diet-microbiota interactions as moderators of human metabolism","volume":"535","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175209_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1473-3099(01)00066-4","article-title":"Effect of antimicrobial agents on the ecological balance of human microflora","volume":"1","author":"Sullivan","year":"2001","journal-title":"Lancet Infect. Dis."},{"issue":"7228","key":"10.1016\/j.ejphar.2022.175209_bib50","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","article-title":"A core gut microbiome in obese and lean twins","volume":"457","author":"Turnbaugh","year":"2009","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejphar.2022.175209_bib51","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/jac\/dkv062","article-title":"Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota","volume":"70","author":"Vervoort","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175209_bib52","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","article-title":"Impact of commonly used drugs on the composition and metabolic function of the gut microbiota","volume":"11","author":"Vich","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175209_bib53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metabol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175209_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12944-018-0801-x","article-title":"The influence of the intestinal microflora to the efficacy of Rosuvastatin","volume":"17","author":"Wang","year":"2018","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejphar.2022.175209_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ebiom.2018.11.035","article-title":"Morten Arendt Rasmussen MA, Trivedi U, Bisgaard H, S\u00f8rensen SJ. Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: a double-blind, randomized, placebo-controlled trial","volume":"38","author":"Wei","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2022.175209_bib56","first-page":"1","article-title":"Diversification of host bile acids by members of the gut microbiota","volume":"9","author":"Winston","year":"2019","journal-title":"Gut Microb."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175209_bib57","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1038\/s41467-018-05336-9","article-title":"Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism","volume":"9","author":"Zarrinpar","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2022.175209_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01693-15","article-title":"Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces","volume":"6","author":"Zaura","year":"2015","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175209_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.taap.2014.03.009","article-title":"Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice","volume":"277","author":"Zhang","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6427","key":"10.1016\/j.ejphar.2022.175209_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9931","article-title":"Separating host and microbiome contributions to drug pharmacokinetics and toxicity","volume":"363","author":"Zimmermann","year":"2019","journal-title":"Science"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:11:23Z","timestamp":1757977883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922004708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":60,"alternative-id":["S0014299922004708"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175209","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum cholesterol increase in statin users associated with antibiotic use: Case-crossover study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175209"}}